Guideline 101: British guideline on the management of asthma - Supporting material

The full printed version of the guideline is available. Included on this page is supporting material which is not available in the printed copy.

Educational slides

• Management of asthma in adults (Powerpoint)
• Management of asthma in children (Powerpoint)

Evidence tables

• Evidence table 4.1: Inhaled short acting beta 2 agonists
• Evidence table 4.10: Rhinitis
• Evidence table 4.11a: Add-on drugs for inhaled steroids: Chromones
• Evidence table 4.11b: Add-on drugs for inhaled steroids: Long acting or oral B2 agonists
• Evidence table 4.11c: Add-on drugs for inhaled steroids: Anticholinergics
• Evidence table 4.11d: Add-on drugs for inhaled steroids: Theophylline, beclomethasone diproponate, budesonide
• Evidence table 4.13a: Immunosuppresive agents
• Evidence table 4.15: Mometasone Furoate dry powder inhalation evidence
• Evidence table 4.19: Allergic bronchopulmonary aspergillosis
• Evidence table 4.2: Ipratopium bromide
• Evidence table 4.21: Aspirin intolerant asthma
• Evidence table 4.22: Combined therapy of inhaled steroids and long acting B2 agonist
• Evidence table 4.23: Anti IgE in asthma
• Evidence table 4.24a: Other preventor therapies - Chromones in children aged 5-12
• Evidence table 4.24b: Other preventor therapies - Chromones in children aged <5
• Evidence table 4.25: Budesonide vs beclomethasone
• Evidence table 4.3a: Long acting B2 agonists in exercise induced asthma
• Evidence table 4.3b: Ketotifen for exercise-induced asthma
• Evidence table 4.3c: Theophyllines in exercise-induced asthma
• Evidence table 4.3d: Leukotriene receptor antagonists in exercise induced asthma
• Evidence table 4.3e: Anti-histamines for exercise-induced asthma
• Evidence table 4.3f: Anti-cholinergic therapy for exercise-induced asthma
• Evidence table 4.3g: Oral B2 agonists for exercise induced asthma
• Evidence table 4.4a: Inhaled corticosteroid vs theophylline
• Evidence table 4.4c: Inhaled corticosteroid vs leukotriene receptor antagonists
• Evidence table 4.4d: Leukotriene receptor antagonists with short-acting beta-agonists
• Evidence table 4.4j: Do Chromones work as first line preventor in children >5 years?
• Evidence table 4.7: High dose step-down
• Evidence table 4.8c: Children with poor asthma control on ICS – Is addition of leukotriene receptor antagonists helpful?
• Evidence table 4.9: Exacerbation